Business Context and Reporting Period
Caring Brands, Inc. (CABR), a Nevada corporation listed on The Nasdaq Stock Market, filed this Form 8-K on March 19, 2026. The filing reports the closing of a Private Investment in Public Equity (PIPE) offering and a concurrent share redemption program involving company insiders.
Key Financial Metrics and Transaction Details
- Capital Raised: Aggregate gross proceeds of approximately $3.6 million from the sale of Series A Convertible Preferred Stock and Common Warrants.
- Securities Issued: 3,789.74 shares of Series A Convertible Preferred Stock (stated value $1,000/share) and 9,473,685 Common Warrants.
- Conversion/Exercise Terms: Preferred stock converts to common stock at $0.40/share; Warrants exercise at $0.40/share.
- Share Redemption: The Company used $3.075 million of net proceeds to redeem 6,250,000 shares of Common Stock from insiders (CEO, Chairman, and NovoDX, Inc.).
- Share Count Impact: Outstanding common stock reduced from 14,761,925 to 8,511,925 shares post-redemption.
- Dividend Rights: Series A Preferred Stock holders are entitled to an 8% dividend payable in cash or common stock.
Material Changes Versus Prior Period
This filing represents a discrete capital event rather than a periodic financial report. The most significant material change is the reduction of the Company's outstanding common share count by approximately 42% due to the insider share redemption. Additionally, the capital structure now includes a new class of convertible preferred stock and a significant number of warrants, introducing potential future dilution subject to beneficial ownership limitations.
Guidance, Outlook, and Risks
- Use of Proceeds: $3.075 million allocated to share redemption; remaining proceeds designated for general corporate and working capital purposes.
- Additional Investment Rights (AIR): The Purchaser has the right to purchase up to an additional $4.0 million of Series A Preferred Stock and Warrants. The conversion/exercise price for these additional shares is set at the lower of 90% of the 10-day average low or the lowest previously issued price.
- Dilution Limits: Issuances upon conversion or exercise are capped at 19.99% of outstanding common stock without shareholder approval. Warrant exercise is also limited to prevent the investor from beneficially owning more than 4.99% of outstanding common stock.
- Liquidity and Trading: There is no trading market for the Series A Preferred Stock or Common Warrants, and the Company does not intend to list them.
- Registration Rights: The Company agreed to file registration statements for the resale of shares issuable upon conversion and warrant exercise.
Investor Verification Checklist
- Verify the exact number of shares outstanding post-redemption (8,511,925) and confirm the reduction in insider holdings.
- Review the "Additional Investment Rights" (AIR) terms to assess the potential for significant near-term dilution at a discount to market price.
- Confirm the Company's ability to service the 8% dividend obligation on the Series A Preferred Stock.
- Monitor the filing of the registration statement required for the resale of unregistered shares.
- Assess the impact of the 19.99% beneficial ownership limitation on the timing of future conversions and warrant exercises.